Pyrimidine nucleoside monophosphate catabolic process

pathway activity — cross-omics
GO:0009131Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Pyrimidine nucleoside monophosphate catabolic process pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Lymphoma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MTHFD1L, RTKN2, and IL7, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine nucleoside monophosphate catabolic process activity versus MTHFD1L in BLOOD_Lymphoma (Pearson r = -0.41).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LymphomaMTHFD1L →-0.814-0.806<.001.00434
BLOOD_LymphomaRTKN2 →-1.500-0.925<.001.00334
CNSIL7 →-1.426-0.943<.001<.00134
LUNG_NSCLC_LUSCRNF113A →-0.986-1.866.008<.00134
BLOOD_LeukemiaHACL1 →-0.644-0.911.002.00334
CNSSTUB1 →-0.804-1.209.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009131 vs MTHFD1L — BLOOD_Lymphoma

Per-sample scatter of Pyrimidine nucleoside monophosphate catabolic process activity vs MTHFD1L in BLOOD_Lymphoma.

Explore this scatter interactively →

Exploration